Ann Vos
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
Papers in
-
- Advanced Chemical Physics Studies 9
- Co-authors
- Robert A. Schoonheydt (8 shared papers)R. Clayton (4 shared papers)Maxwell D. Cummings (3 shared papers)Jan Willem Thuring (2 shared papers)Peter Cherepanov (1 shared paper)S. Hare (1 shared paper)Paul Geerlings (7 shared papers)Frank De Proft (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)ACS Medicinal Chemistry Letters (3 papers)Antiviral Research (2 papers)The Journal of Physical Chemistry B (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Ann Vos
32 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Virology 335
- Infectious Diseases 481
- Catalysis 142
- Inorganic Chemistry 265
- Hepatology 61
Countries citing papers authored by Ann Vos
This map shows the geographic impact of Ann Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Vos more than expected).
Fields of papers citing papers by Ann Vos
This network shows the impact of papers produced by Ann Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Vos. The network helps show where Ann Vos may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Vos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 256 | |
| 2 | 2001 | 163 | |
| 3 | 2008 | 142 | |
| 4 | 2015 | 90 | |
| 5 | 2002 | 88 | |
| 6 | 2010 | 70 | |
| 7 | 2018 | 68 | |
| 8 | 2010 | 53 | |
| 9 | 2011 | 43 | |
| 10 | 2018 | 43 | |
| 11 | 2019 | 30 | |
| 12 | 2003 | 30 | |
| 13 | 2011 | 28 | |
| 14 | 2017 | 25 | |
| 15 | 2020 | 20 | |
| 16 | 2023 | 16 | |
| 17 | 2021 | 16 | |
| 18 | 2006 | 16 | |
| 19 | 2005 | 15 | |
| 20 | 2017 | 14 |
About Ann Vos
Ann Vos is a scholar working on Molecular Biology, Atomic and Molecular Physics, and Optics, Inorganic Chemistry, Infectious Diseases and Computational Theory and Mathematics, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include Advanced Chemical Physics Studies (9 papers), Zeolite Catalysis and Synthesis (8 papers), Computational Drug Discovery Methods (6 papers), HIV/AIDS drug development and treatment (5 papers), Catalysis and Oxidation Reactions (4 papers), HIV Research and Treatment (4 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). The work is most often cited by research in Virology (335 citations), Infectious Diseases (481 citations), Catalysis (142 citations), Inorganic Chemistry (265 citations) and Hepatology (61 citations). Ann Vos has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Robert A. Schoonheydt, R. Clayton, Maxwell D. Cummings, Jan Willem Thuring, Peter Cherepanov, S. Hare, Paul Geerlings, Frank De Proft, Juergen Hafner and François Hutschka. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Antiviral Research, The Journal of Physical Chemistry B and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.